Search Results - "Lacerna, Leo"

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer by BRUFSKY, Adam, HARKER, W. Graydon, BECK, J. Thaddeus, CARROLL, Robert, TAN-CHIU, Elizabeth, SEIDLER, Christopher, HOHNEKER, John, LACERNA, Leo, PETRONE, Stephanie, PEREZ, Edith A

“…Treatment with aromatase inhibitors decreases bone mineral density (BMD) and may increase the risk of fractures in postmenopausal women with early-stage breast…”
Get full text

Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006 by Weitzman, Richard, Sauter, Nicholas, Eriksen, Erik Fink, Tarassoff, Peter G, Lacerna, Leo V, Dias, Rosh, Altmeyer, Anne, Csermak-Renner, Katalin, McGrath, Lynne, Lantwicki, Linda, Hohneker, John A

“…Abstract In light of recent reports of osteonecrosis of the jaw (ONJ) in cancer patients whose treatment regimens include an intravenous bisphosphonate,…”
Get full text

Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer by Ryan, Christopher W, Huo, Dezheng, Demers, Laurence M, Beer, Tomasz M, Lacerna, Leo V

“…Androgen deprivation therapy in patients with prostate cancer is associated with bone loss and an increased risk of fractures. Zoledronic acid protects against…”
Get more information

The Effect of Zoledronic Acid on Bone Mineral Density in Patients Undergoing Androgen Deprivation Therapy by Israeli, Ron S, Rosenberg, Steven J, Saltzstein, Daniel R, Gottesman, James E, Goldstein, Howard R, Hull, Gerald W, Tran, Diep N.H, Warsi, Ghulam M, Lacerna, Leo V

“…Abstract Purpose The aim of this study was to evaluate the efficacy and safety of zoledronic acid compared with placebo in preventing bone mineral density…”
Get full text

Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases by Polascik, Thomas J., Given, Robert W., Metzger, Charles, Julian, Sydney R., Vestal, James C., Karlin, Gary S., Barkley, Craig S., Bilhartz, David L., McWhorter, Laura T., Lacerna, Leo V.

“…To evaluate the efficacy and safety of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases who were…”
Get full text

Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors by Lacerna, Leo, Hohneker, John

“…Painful and life-threatening skeletal complications are common in patients with advanced cancer metastatic to bone. Patients with breast cancer and multiple…”
Get full text

Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate Therapy by Vogel, Charles L., Yanagihara, Ronald H., Wood, Albert J., Schnell, Frederick M., Henderson, Charles, Kaplan, Barry H., Purdy, Malcolm H., Orlowski, Richard, Decker, Jodi L., Lacerna, Leo, Hohneker, John A.

“…An open‐label study conducted in community centers assessed the safety of zoledronic acid 4 mg intravenously over 15 minutes every 3–4 weeks as treatment of…”
Get full text